Carnitor (Levocarnitine) Patent Expiration, LOE Window & CMS Spending

Carnitor (Levocarnitine) by Leadiant: Off-Patent Genericized (AB Competition), 2 AB generics, $5.1M 2024 CMS Part D & Medicaid spend, and 2 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorLeadiant
FDA Application & PathwayN018948 (NDA)
Exclusivity / Cliff HorizonOff-Patent Genericized (AB Competition)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors2
2024 CMS Total Public Spend$5.1M
2024 Medicare Part D Spend$226K
2024 Medicaid Spend$4.8M
Reported Wholesale Price Change (CA SB 17)2 WAC filings (max 48.7% 2-yr change)